QT variability improves risk stratification in patients with dilated cardiomyopathy
C Fischer1, A Seeck, R Schroeder
1Department of Medical Engineering and Biotechnology, University of Applied Sciences Jena, Germany.
Physiological Measurement
|March 24, 2015
Summary
QT variability (QTV) analysis improves risk stratification in dilated cardiomyopathy (DCM) patients. Combining QTV with blood pressure variability (BPV) and clinical data offers superior prediction of sudden cardiac death risk.
Area of Science:
- Cardiology
- Biomedical Engineering
- Data Science
Background:
- Systolic and diastolic blood pressure variability (BPV) and segmented Poincare plot analysis (SPPA) aid risk stratification in dilated cardiomyopathy (DCM).
- Traditional heart rate variability analysis is insufficient for risk stratification in DCM patients.
- There is a need for improved risk stratification methods in DCM.
Purpose of the Study:
- To enhance risk stratification in DCM patients using a multivariate technique incorporating QT variability (QTV).
- To evaluate the effectiveness of combining BPV, SPPA, and QTV for predicting adverse outcomes in DCM.
Main Methods:
- Recruited 56 low-risk and 13 high-risk DCM patients.
- Applied various BPV and QTV methods, including symbolic dynamics and segmented Poincare plot analysis.
- Utilized multivariate discriminate analysis (DA) with different combinations of indices.
Main Results:
- A multivariate DA model using one BPV index (DBP(Shannon)) and one QTV index (QTV(log)) achieved an AUC of 92%, sensitivity of 92.3%, and specificity of 89.3%.
- An electrocardiogram-only analysis combining SPPA and QTV yielded an AUC of 88.3%.
- A three-index model (clinical, BPV, QTV) reached an AUC of 95.7%, with 100% sensitivity and 85.7% specificity.
Conclusions:
- QT variability (QTV) analysis in a multivariate approach significantly improves risk stratification for DCM patients.
- The combination of QTV with BPV and clinical data enhances the prediction of sudden cardiac death risk in DCM.
- Multivariate analysis incorporating QTV offers a promising tool for identifying high-risk DCM patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
803
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Cardiomyopathy III: Hypertrophic Cardiomyopathy
793
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cardiomyopathy V: Interprofessional Care
711
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
711
Mitral Stenosis II: Clinical features and Diagnostic Tests
502
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
502
Cardiomyopathy I: Introduction and Classification
856
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
856
Dysrhythmias V: Evaluating Dysrhythmias
488
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
488


